Consensus Clover Health Investments, Corp.

Equities

CLOV

US18914F1030

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-22 pm EDT			5-day change	1st Jan Change
0.6222 ^USD	-2.11%		-2.20%	-34.65%

Mar. 19	Clover Health Launches New Clinical Program in Partnership with quarter Health to Address Serious Mental Illness	CI
Mar. 18	Clover Health Investments, Corp.(NasdaqGS:CLOV) dropped from S&P Health Care Services Select Industry Index	CI

Evolution of the average Target Price on Clover Health Investments, Corp.

Price target over the last 5 years

History of analyst recommendation changes

613696bc32fe794586d91d5c902.-tH552WjPpRKAqpN9NSVnHaAEtox0h_yGfBPWVvOvDg.n52mjDzoB_p_YNIJpezU_wa1IbZrg3iFSsQhaz6-1VSJpbChEcRf0x5L7w~474718bc5d30c0e3070b72a527bab6d1

Analyst Recommendations on Clover Health Investments, Corp.

Citigroup Adjusts Price Target on Clover Health Investments to $1.50 From $1, Maintains Neutral Rating	23-08-11	MT
Canaccord Genuity Adjusts Price Target on Clover Health Investments to $3 From $4, Maintains Buy Rating	23-03-06	MT
Credit Suisse Trims Clover Health Investments' PT to $1.25 From $2.50, Says Multiples Across Tech Managed Care Organization Space Have Compressed; Keeps Underperform Rating	23-03-06	MT
Credit Suisse Trims Clover Health Investments' Price Target to $2.50 From $3, Lowers 2022 to 2024 Revenue Estimatesl; Keeps Underperform Rating	22-11-21	MT
Citigroup Adjusts Price Target on Clover Health Investments to $1.80 From $3.50, Maintains Neutral Rating	22-11-16	MT
SVB Securities Adjusts Price Target on Clover Health Investments to $1.50 From $3, Maintains Market Perform Rating	22-11-08	MT
Clover Health Medicare Advantage Plans Earn 3.5 Star Rating for 2023	22-10-11	GL
Clover Health Medicare Advantage Plans Earn 3.5 Star Rating for 2023	22-10-11	GL
Citigroup Raises Clover Health Investments Price Target to $3.50 From $3, Maintains Neutral Rating	22-08-09	MT
BofA Securities Adjusts Clover Health Investments Price Target to $2 From $2.50, Maintains Underperform Rating	22-06-15	MT
BofA Securities Assess Risks to Managed Care Sector Amid Shifting Regulatory Environment, Market Disruption	22-05-26	MT
SVB Securities Raises Clover Health Investments Price Target to $3 From $2.50, Maintains Market Perform Rating	22-05-10	MT
Canaccord Genuity Starts Clover Health Investments at Buy With $6 Price Target	22-02-02	MT
Cowen Upgrades Clover Health Investments to Market Perform From Underperform, Adjusts Price Target to $3 From $7	22-02-02	MT
SVB Leerink Starts Clover Health Investments at Market Perform With $3 Price Target	22-01-19	MT
Credit Suisse Downgrades Clover Health Investments to Underperform from Neutral, Says Need to Raise Capital Remains; Adjusts PT to $3.50 from $9	22-01-07	MT
Clover Health Investments : PPO Plan Gets Higher Rating From Centers for Medicare and Medicaid Services	21-10-08	MT
CLOVER HEALTH INVESTMENTS : Cowen Initiates Clover Health Investments With Underperform Rating, $7 Price Target	21-09-09	MT
CLOVER HEALTH INVESTMENTS : JPMorgan Downgrades Clover Health Investments to Underweight From Neutral; Price Target is $9	21-07-12	MT
CLOVER HEALTH INVESTMENTS : BofA Securities Downgrades Clover Health Investments to Underperform From Neutral; Price Target is $10	21-06-10	MT
CLOVER HEALTH INVESTMENTS : Credit Suisse Lowers Clover Health Investments' PT to $9 from $10 Based on Revised Estimates, Keeps Neutral Rating	21-05-19	MT
CLOVER HEALTH INVESTMENTS : Citigroup Adjusts Price Target on Clover Health Investments to $10 From $13, Maintains Buy Rating	21-05-18	MT
CLOVER HEALTH INVESTMENTS : BofA Securities Downgrades Clover Health Investments to Neutral Rating From Buy on Disappointing Q1 Results, Lowers PT to $9 From $15	21-05-17	MT
CLOVER HEALTH INVESTMENTS : Credit Suisse Initiates Coverage on Clover Health Investments With Neutral Rating, $10 Price Target	21-03-09	MT
CLOVER HEALTH INVESTMENTS : Citigroup Initiates Coverage on Clover Health Investments With Buy Rating, $19 Price Target	21-02-02	MT